Extension Study of Participants From SPG302-ALZ-101

Clinical trial NCT06833281 · TERMINATED

Trial details

NCT number: NCT06833281
Sponsor: Spinogenix
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2025-03-25
Primary completion: 2025-07-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.